Associazione Nazionale Medici Cardiologi Ospedalieri

CONGRESS ABSTRACT

CONGRESS ABSTRACT

Categorie
CONFOUNDING CARDIAC MARKERS IN A CASE OF COVID-19 MYOCARDITIS
Anno:
2023
BACKGROUND-AIM A man of 81 years, with previous coronary artery disease, unrecognized myocardial infarction, carrier of implanted pacemaker, presented to the cardiology department for a scheduled hospitalization to treat shortness of breath and symptoms of heart failure. There was no chest pain, ECG poorly assessable for pacemaker-induced rhythm, cardiac…
Incidence and main clinical characteristics of myocarditis in Piacenza Province in the last five years
Anno:
2023
Myocarditis is an inflammatory disease of cardiac muscle caused by a variety of etiologies, myocardial involvement and clinical presentations ranging from chest pain to extreme conditions such as cardiogenic shock or death. The variability in presentation reflects the variability in histological disease severity, etiology, and disease stage at presentation….
Miocardite linfocitaria autoimmune: one size does not fit all
Anno:
2023
La miocardite fulminante (MF) è una cardiomiopatia infiammatoria ad insorgenza acuta, con evoluzione rapidamente progressiva, potenzialmente fatale, realizzante quadri di shock cardiogeno ed aritmie incessanti. Spesso vi è necessità di supporto aminico o meccanico al circolo in fase acuta, nell’attesa di ottenere il più rapidamente possibile una diagnosi istologica…
CASO DI SHOCK CARDIOGENO DA MIOCARDITE FULMINANTE IN PAZIENTE COVID19 POSITIVO TRATTATO MEDIANTE ECPELLA
Anno:
2023
Caso clinico Uomo di 60 anni, fumatore, anamnesi cardiovascolare negativa. Nel 2018 miosite parainfettiva dopo sindrome influenzale, responsiva a corticosteroide. Accede in PS per sincope con tampone nasofaringeo positivo per COVID19, dimesso dopo idratazione ed ematochimici nella norma. Il giorno seguente nuovo accesso in PS per astenia, dispnea e…
Evoluzione benigna a lungo termine della miopericardite da vaccino anti Sars-CoV 2
Anno:
2023
Background. La miopericardite a seguito del vaccino contro la malattia da Sars-CoV2 (COVID-19) è un'entità descritta, ma la sua evoluzione a lungo termine non è ancora chiara. Metodi: I pazienti con diagnosi di miopericardite dopo il vaccino ad  mRNA COVID-19 rappresentavano la nostra popolazione. La valutazione clinica, i test…
OUTCOME AND MORPHO-FUNCTIONAL CHANGES ON CARDIAC MAGNETIC RESONANCE IN PATIENT WITH ACUTE MYOCARDITIS FOLLOWING MRNA COVID 19 VACCINATION
Anno:
2023
BACKGROUND: MessengerRNA (mRNA) COVID-19 vaccination has been associated with a higher-than-expected occurrence of acute myocarditis. Scarce information is available on mid-term prognosis and changes in cardiac function, volumes, and tissue characterization on cardiac magnetic resonance (CMR).  METHODS: Retrospective, multicenter study including patients with a definite diagnosis of acute myocarditis…
Fulminant myocarditis with spontaneous resolution after COVID 19 and allergic episode: MIS-A or allergic myocarditis?
Anno:
2023
Clinical case:  23-year-old male. No medical history  Not vaccinated for Sars-Cov2;  Recent Sars-Cov2 infection (negative antigenic swab on 03/01/22);  Pharyngodynia treated with ibuprofen + ciprofloxacin and amoxicillin ac clavulanic acid(suspended for purpuric lesions on hands) After 5 days from onset of symptoms, access to PS for loss of consciousness. …
BEHIND MYOCARDITIS DIAGNOSIS
Anno:
2023
Background: Myocarditis is an inflammatory disease of myocardium, with a wide range of clinical presentation. Myocarditis may mimic acute coronary syndrome (ACS), but it is also possible an overlap between these two different syndromes, as we considered the close relationship between wide inflammatory systemic condition and coronary atherosclerotic plaque…
CARDIOMIOPATIE E GENETICA: ATTIVAZIONE DI UN PERCORSO CONDIVISO. ESPERIENZA DEL CENTRO DI CUNEO
Anno:
2023
Negli ultimi anni l’indagine genetica è diventata parte attiva del percorso diagnostico e dell’iter terapeutico del paziente cardiologico con cardiomiopatie. L’avviamento del paziente ad indagine genetica assume un ruolo fondamentale come elemento discriminante nel percorso clinico-decisionale del probando inserendosi in una visione di medicina di precisione ed acquisendo un…
ROLE OF RESTRICTIVE DIASTOLIC DYSFUNCTION FOR RISK STRATIFICATION OF PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY: A BAYESIAN MODEL AVERAGING
Anno:
2023
BACKGROUND Hypertrophic cardiomyopathy (HCM) is characterized by increased left ventricular (LV) stiffness, leading to raised ventricular filling pressures and restrictive diastolic dysfunction (RDD), in itself independently associated with an increased risk of a clinical deterioration. We assessed whether echocardiography evaluation of diastolic function in HCM could yield prognostic value…